Palisade Capital Management LLC Nuvasive Inc Transaction History

Palisade Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$47.43 - $60.75 $213,435 - $273,375	-4,500 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$43.51 - $66.59 $195,795 - $299,655	4,500 New	4,500 $250,000
Q3 2018 Nov 14, 2018	SELL	$52.03 - $71.41 $208,120 - $285,640	-4,000 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$48.15 - $56.68 $60,187 - $70,850	-1,250 Reduced 23.81%	4,000 $208,000
Q1 2018 May 09, 2018	BUY	$46.03 - $61.28 $241,657 - $321,720	5,250 New	5,250 $274,000
Q4 2017 Feb 09, 2018	SELL	$50.58 - $60.79 $202,320 - $243,160	-4,000 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$53.54 - $68.0 $214,160 - $272,000	4,000	4,000 $222,000

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.